Poster exhibition
Respiratory viruses

Programm

• • Poster
  • P 416

  From pandemics past to present: Unveiling the role of TMPRSS2 in the proteolytic activation of pandemic and zoonotic influenza- and Coronaviruses in human airway cells

  • Marie Schwerdtner (Marburg / DE)

   Respiratory viruses
• • Poster
  • P 417

  Long COVID-19: Exploring its risk factors and consequences in a German cohort

  • Laura Thümmler (Essen / DE)

   Respiratory viruses
• • Poster
  • P 418

  Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera

  • Janine Kimpel (Innsbruck / AT)

   Respiratory viruses
• • Poster
  • P 419

  Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization

  • Chiara Pastorio (Ulm / DE)

   Respiratory viruses
• • Poster
  • P 420

  T-cell responses following vaccination with an mRNA respiratory syncytial virus vaccine, mRNA-1345, in older adults

  • Dr. Jennifer Tufts (München / DE)

   Respiratory viruses
• • Poster
  • P 421

  Molnupiravir-based mutagenesis as a platform for in-vitro selection of antibody-escape mutations in the SARS-CoV-2 spike protein

  • Priya Kumar (Goettingen / DE)

   Respiratory viruses
• • Poster
  • P 422

  Validation of precise cut lung slices (PCLS) as an ex vivo model to study early host response against Influenza A virus and Streptococcus pneumoniae

  • Dr. Helena Choltus (Genève / CH)

   Respiratory viruses
• • Poster
  • P 423

  Study of viral respiratory infections in an in vitro model of polarized primary human airway epithelial cells from children and adults

  • Dr. Mathilde Bellon (Geneva / CH)

   Respiratory viruses
• • Poster
  • P 424

  KLK13 inhibits SARS-CoV-2 cell entry and syncytia formation via proteolytic cleavage of spike protein

  • Professor Guigen Zhang (Guangzhou / CN)

   Respiratory viruses
• • Poster
  • P 426

  Establishment of a high-throughput immunoassay to quantify HRV infection

  • Carina Meta Friedrich (Ulm / DE)

   Respiratory viruses
• • Poster
  • P 427

  Investigation of strain-specific fingerprints in influenza A virus cell activation and endosomal uptake

  • Yang Fu (Braunschweig / DE)

   Respiratory viruses
• • Poster
  • P 428

  Neutralization assays with SARS-CoV-2 pseudoviruses

  • Dominik Moll (Wien / AT)

   Respiratory viruses
• • Poster
  • P 429

  The origin of SARS-CoV-2 and its furin cleavage site, a new and parsimonious evolutionary model

  • Dr. jonathan Latham (Ithaca / US)

   Respiratory viruses
• • Poster
  • P 430

  Integrated virological and genomic surveillance of SARS-CoV-2 in Germany: Keeping a systematic view on viral evolution and adaptation to human hosts

  • Dr. Thorsten Wolff (Berlin / DE)

   Respiratory viruses
• • Poster
  • P 431

  A simple system to test the capacity of filter materials to retain respiratory viruses

  • Dr. Jasmin Fertey (Leipzig / DE)

   Respiratory viruses
• • Poster
  • P 432

  Fluorescent fate mapping of cells surviving an acute respiratory RNA virus infection in vivo

  • Lisa Kern (Freiburg / DE)

   Respiratory viruses
• • Poster
  • P 433

  Mucus: A potential barrier for zoonotic viral transmission?

  • Maximilian Busch (Braunschweig / DE)

   Respiratory viruses
• • Poster
  • P 434

  Host cell response upon Co-infection with SARS-CoV-2 and Influenza strains

  • Melinda Kolling (Frankfurt am Main / DE)

   Respiratory viruses
• • Poster
  • P 435

  Building Blocks of Understanding: Constructing a Reverse Genetic Platform for Investigating SARS-CoV-2

  • Marco Olguin Nava (Würzburg / DE)

   Respiratory viruses
• • Poster
  • P 437

  DMSO impacts efficacy of human adenovirus (HAdV) infection in HepaRG cells

  • Dr. Julia Mai (Freiburg / DE)

   Respiratory viruses
• • Poster
  • P 438

  Infection of human lung organoids with coronaviruses, a promising in vitro model system to investigate respiratory tract infectious diseases

  • Simon Herrmann (Hamburg / DE)

   Respiratory viruses
• • Poster
  • P 439

  Polarized human lung epithelial cell cultures are a suitable model for phenotyping assessment of emerging SARS-CoV-2 variants

  • Dr. Christin Mache (Berlin / DE)
  • Dr. Jessica Schulze (Berlin / DE)

   Respiratory viruses
• • Poster
  • P 440

  Follow-up: Respiratory viruses dynamics and interactions: ten years of surveillance in central Europe

  • Dr. Ralf Eggeling (Tübingen / DE)
  • Florian König (Tübingen / DE)

   Respiratory viruses
• • Poster
  • P 441

  Deciphering tissue tropism in avian Coronavirus: Insights from reverse genetics and mutational analysis of the spike protein

  • Marco Neubauer (Berlin / DE)

   Respiratory viruses
• • Poster
  • P 442

  Evaluation of gene expression for L-Dopa decarboxylase (DDC) in individuals diagnosed with COVID-19 within the Moroccan population

  • Dr. Oumaima Laazaazia (Casablanca / MA)

   Respiratory viruses
• • Poster
  • P 443

  Investigating the effect of the RSV A-ON1-defining nucleotide duplication on infection in primary human respiratory epithelial cells

  • Kshitija Gadekar (Würzburg / DE)

   Respiratory viruses
• • Poster
  • P 444

  Establishment of human Precision Cut Lung Organ Slices as an ex vivo model for human respiratory viruses

  • Melina Hardt (Graz / AT)

   Respiratory viruses
• • Poster
  • P 445

  A spike mutation compatible with SARS-CoV-2 replication in natura confers resistance to fusion peptide-binding antibodies

  • Dr. Vu Thuy Khanh Le-Trilling (Essen / DE)

   Respiratory viruses
• • Poster
  • P 446

  A pre-existing HIV infection alters the capacity of SARS-CoV-2-specific antibodies to trigger cellular phagocytosis

  • Professor Christina B. Karsten (Essen / DE)

   Respiratory viruses
• • Poster
  • P 447

  Unraveling the molecular mechanisms of influenza virus reassortment through High-Throughput single particle sequencing

  • Uddhav Babaso Ambi (Würzburg / DE)

   Respiratory viruses